M. Hugo de Vries

411 total citations
17 papers, 321 citations indexed

About

M. Hugo de Vries is a scholar working on Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, M. Hugo de Vries has authored 17 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in M. Hugo de Vries's work include Drug Transport and Resistance Mechanisms (5 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). M. Hugo de Vries is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). M. Hugo de Vries collaborates with scholars based in Netherlands, United Kingdom and France. M. Hugo de Vries's co-authors include M. Raghoebar, J. Van Harten, J. Noordhoek, Andries S. Koster, Paul M. Grasby, R. Alexander Bantick, G.A. Hofman, Plm Jansen, Frank A. Redegeld and Ella Hirani and has published in prestigious journals such as Neuropsychopharmacology, Biochemical Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

M. Hugo de Vries

17 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hugo de Vries Netherlands 10 97 91 77 74 64 17 321
AF Cohen Netherlands 11 52 0.5× 65 0.7× 56 0.7× 99 1.3× 90 1.4× 15 444
Rustan Johansson Sweden 10 56 0.6× 64 0.7× 106 1.4× 111 1.5× 48 0.8× 17 471
O Varoquaux France 12 38 0.4× 103 1.1× 71 0.9× 87 1.2× 24 0.4× 23 393
Katrin M. Kirschbaum Germany 13 79 0.8× 77 0.8× 204 2.6× 80 1.1× 116 1.8× 19 511
Jun Miura Japan 10 90 0.9× 47 0.5× 82 1.1× 69 0.9× 48 0.8× 24 399
Anders Lidén Sweden 11 78 0.8× 64 0.7× 117 1.5× 68 0.9× 56 0.9× 14 455
G. John Digregorio United States 12 50 0.5× 61 0.7× 19 0.2× 52 0.7× 34 0.5× 33 353
Insong J. Lee United States 10 95 1.0× 108 1.2× 18 0.2× 71 1.0× 99 1.5× 13 416
Joyce A. Cheripko United States 9 28 0.3× 70 0.8× 94 1.2× 51 0.7× 47 0.7× 10 494
Şükrü Aynacıoğlu Türkiye 7 98 1.0× 60 0.7× 36 0.5× 74 1.0× 67 1.0× 12 338

Countries citing papers authored by M. Hugo de Vries

Since Specialization
Citations

This map shows the geographic impact of M. Hugo de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hugo de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hugo de Vries more than expected).

Fields of papers citing papers by M. Hugo de Vries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hugo de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hugo de Vries. The network helps show where M. Hugo de Vries may publish in the future.

Co-authorship network of co-authors of M. Hugo de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hugo de Vries. A scholar is included among the top collaborators of M. Hugo de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hugo de Vries. M. Hugo de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bantick, R. Alexander, M. Hugo de Vries, & Paul M. Grasby. (2005). The effect of a 5-HT1A receptor agonist on striatal dopamine release. Synapse. 57(2). 67–75. 22 indexed citations
2.
Vries, M. Hugo de. (2004). SLV 308: plasma levels of effective doses in MPTP-treated marmosets in comparison with plasma levels and D2 receptor occupancy (PET) in humans. Clinical Pharmacology & Therapeutics. 75(2). P70–P70. 1 indexed citations
3.
Bantick, R. Alexander, Eugenii A. Rabiner, Ella Hirani, et al.. (2003). Occupancy of Agonist Drugs at the 5-HT1A Receptor. Neuropsychopharmacology. 29(5). 847–859. 41 indexed citations
4.
Solinge, Hanna van & M. Hugo de Vries. (2001). De joden in Nederland anno 2000. Demografisch profiel en binding aan het jodendom. UvA-DARE (University of Amsterdam). 7 indexed citations
6.
Harten, J. Van, et al.. (1993). Pharmacokinetics of Fluvoxamine Maleate in Patients with Liver Cirrhosis after Single-Dose Oral Administration. Clinical Pharmacokinetics. 24(2). 177–182. 31 indexed citations
7.
Vries, M. Hugo de, et al.. (1993). Pharmacokinetics of fluvoxamine maleate after increasing single oral doses in healthy subjects. Biopharmaceutics & Drug Disposition. 14(4). 291–296. 21 indexed citations
8.
Vries, M. Hugo de, et al.. (1992). Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly Subjects. Therapeutic Drug Monitoring. 14(6). 493–498. 50 indexed citations
9.
Vries, M. Hugo de, et al.. (1992). Decarboxylation of l-Dopa in the Rat Isolated Vascularly Perfused Small Intestine: Contribution to Systemic Elimination and Dose-dependent First Pass Effect. Journal of Pharmacy and Pharmacology. 44(4). 311–314. 4 indexed citations
10.
Vries, M. Hugo de, P. de Koning, A. Grahnén, et al.. (1991). Dose-proportionality of eltoprazine. European Journal of Clinical Pharmacology. 41(5). 485–488. 6 indexed citations
11.
Vries, M. Hugo de, G.A. Hofman, Andries S. Koster, & J. Noordhoek. (1989). Absorption and presystemic glucuronidation of 1-naphthol in the vasculary fluorocarbon emulsion perfused rat small intestine: the influence of the luminal flow rate and intraluminal binding. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(5). 583–587. 2 indexed citations
12.
Vries, M. Hugo de, G.A. Hofman, Andries S. Koster, & J. Noordhoek. (1989). Absorption and presystemic glucuronidation of 1-naphthol in the vascularly fluorocarbon emulsion perfused rat small intestine. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(2). 239–245. 13 indexed citations
13.
Vries, M. Hugo de, G.A. Hofman, Andries S. Koster, & J. Noordhoek. (1989). Systemic intestinal metabolism of 1-naphthol. A study in the isolated vascularly perfused rat small intestine.. Drug Metabolism and Disposition. 17(5). 573–578. 20 indexed citations
14.
Vries, M. Hugo de, Frank A. Redegeld, Andries S. Koster, et al.. (1989). Hepatic, intestinal and renal transport of 1-naphthol-β-d-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(5). 588–592. 50 indexed citations
15.
Dijk, Anouk van, et al.. (1989). A ready-to-use activated charcoal mixture. Pharmacy World & Science. 11(2). 56–60. 5 indexed citations
16.
Vries, M. Hugo de, et al.. (1989). Pharmacokinetic Modelling of the Effect of Activated Charcoal on the Intestinal Secretion of Theophylline, using the Isolated Vascularly Perfused Rat Small Intestine. Journal of Pharmacy and Pharmacology. 41(8). 528–533. 9 indexed citations
17.
Vries, M. Hugo de, Geny M. M. Groothuis, Gerard J. Mulder, Nguyen Thi Thu Hang, & Dirk K. F. Meijer. (1985). Secretion of the organic anion harmol sulfate from liver into blood. Biochemical Pharmacology. 34(12). 2129–2135. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026